Interaction of substituted phenoxazine chemosensitizers with bovine serum albumin

Journal of Pharmaceutical and Biomedical Analysis

Volumn 21, Issue 4, 1999, Pages 775-785

  Channu, B C ^a   Kalpana, H N ^a   Eregowda, G B ^a   Dass, Chhabil ^b   Houghton, P J ^c   Thimmaiah, K N ^a  

^a UNIVERSITY OF MYSORE   (India)

^b University of Memphis   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Bovine serum albumin; Hydrophobic interaction; Phenoxazine

Indexed keywords

10 (3' N PYRROLIDINOPROPYL) 2 CHLOROPHENOXAZINE; 10 (3' N PYRROLIDINOPROPYL) 2 TRIFLUROMETHYLPHENOXAZINE; 10 [3' [N BIS(HYDROXYETHYL)AMINO]PROPYL] 2 CHLOROPHENOXAZINE; 10 [3' [N BIS(HYDROXYETHYL)AMINO]PROPYL] 2 TRIFLUOROMETHYLPHENOXAZINE; 10 [3' [N BIS(HYDROXYETHYL)AMINO]PROPYL]PHENOXAZINE; BOVINE SERUM ALBUMIN; PHENOXAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; DRUG BINDING; DRUG PROTEIN BINDING; EQUILIBRIUM DIALYSIS; GEL FILTRATION; PRIORITY JOURNAL;

ASPIRIN; BINDING SITES; BINDING, COMPETITIVE; CHROMATOGRAPHY, GEL; DIALYSIS; DRUG INTERACTIONS; DRUG RESISTANCE, MULTIPLE; HYDROXYZINE; OXAZINES; SERUM ALBUMIN, BOVINE;

EID: 0032760691     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(99)00187-9     Document Type: Article

References (26)

1. Krieglstein J., Meiler W., Staab J. Biochem. Pharmacol. 21:1972;985-997.
2. Hulshoff A., Perrin J.H. J. Med. Chem. 20:1977;430-439.
3. Glasser H., Krieglstein J. Naunyn-Schmiedebergs Arch. Pharmacol. 265:1970;331.
4. C.F. Boehringer, Soehne G.m.b.H, Belgium Patent 631 122 (1963); Chem. Abstr. 60 (1964) 14514g.
5. Smith Kline, French Lab, British Patent 898 073; Chem. Abstr. 27 (1962) 12505g.
6. M.P. Olmsted, US Patent 2, 947, 746 (1960); Chem. Abstr. 55 (1961) 11443h.
7. Societe des Usines Chimiques Rhone-Poulene, French Patent (1958) 1, 169, 518; Chem. Abstr. 55 (1961) 3628c.
8. P.N. Craig, US Patent 2, 947, 747 (1960); Chem. Abstr. 55 (1961) 580g.
9. Ribbentrop A., Schaumann W. Arch. Int. Pharmacodyn. Ther. 149:1964;374-384.
10. Gel A.E., Avakian S. J. Med. Chem. 6:1963;809-811.
11. A. Girard, US Patent 3, 048, 586 (1962); Chem. Abstr. 58 (1963) 1471g.
12. Rogers W.P., Craig J.C., Warwick G.P. Br. J. Pharmacol. 10:1955;340-342.
13. Thimmaiah K.N., Horton J.K., Qian X.D., Beck W.T., Houghton J.A., Houghton P.J. Cancer Commun. 2:1990;249-259.
14. Thimmaiah K.N., Horton J.K., Seshadri R., Israel M., Houghton J.A., Harwood F.C., Houghton P.J. J. Med. Chem. 35:1992;3358-3364.
15. Horton J.K., Thimmaiah K.N., Harwood F.C., Kuttesh J.D., Houghton P.J. Mol. Pharmacol. 44:1993;552-559.
16. Thimmaiah K.N., Jayashree B.S., Germain G.S., Houghton P.J., Horton J.K. Oncol. Res. 10:1998;29-41.
17. G.B. Eregowda, H.N. Kalpana, R. Hegde, K.N. Thimmaiah, Ind. J. Chem. Section B, accepted.
18. Eregowda G.B., Krishnegowda G., Kalpana H.N., Channu B.C., Dass C., Horton J.K., Houghton P.J., Thimmaiah K.N. Asian J. Chem. 11(3):1999;878-905.
19. Zamora J.M., Pearce H.L., Beck W.T. Mol. Pharmacol. 33:1988;454-462.
20. Bird A.E., Marshall A.C. Biochem. Pharmacol. 16:1967;2275.
21. Hansch C. J. Med. Chem. 11:1968;920.
22. Hansch C., Fujita T. J. Am. Chem. Soc. 86:1964;1616.
23. Hansch C., Kiehs K., Lawrence G.L. J. Am. Chem. Soc. 87:1965;5770.
24. Scholtan W., Schlossmann K., Rosenkranz H. Arzneimittelforschung. 18:1968;767.
25. Kauzmann W. Adv. Protein Chem. 14:1959;1.
26. Franz J.W., Jahnchen E., Krieglstein J. Naunyn Schmiedebergs Arch. Pharmacol. Exp. Pathol. 264:1969;462.